625 related articles for article (PubMed ID: 29908362)
21. MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T.
Tang A; Dzyubak B; Yin M; Schlein A; Henderson WC; Hooker JC; Delgado TI; Middleton MS; Zheng L; Wolfson T; Gamst A; Loomba R; Ehman RL; Sirlin CB
Eur Radiol; 2022 May; 32(5):2937-2948. PubMed ID: 34928415
[TBL] [Abstract][Full Text] [Related]
22. Comparative diagnostic performance of ultrasound shear wave elastography and magnetic resonance elastography for classifying fibrosis stage in adults with biopsy-proven nonalcoholic fatty liver disease.
Zhang YN; Fowler KJ; Boehringer AS; Montes V; Schlein AN; Covarrubias Y; Wolfson T; Hong CW; Valasek MA; Andre MP; Loomba R; Sirlin CB
Eur Radiol; 2022 Apr; 32(4):2457-2469. PubMed ID: 34854929
[TBL] [Abstract][Full Text] [Related]
23. Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Imajo K; Honda Y; Kobayashi T; Nagai K; Ozaki A; Iwaki M; Kessoku T; Ogawa Y; Takahashi H; Saigusa Y; Yoneda M; Kirikoshi H; Utsunomiya D; Aishima S; Saito S; Nakajima A
Clin Gastroenterol Hepatol; 2022 Apr; 20(4):908-917.e11. PubMed ID: 33340780
[TBL] [Abstract][Full Text] [Related]
24. Magnetic resonance elastography plus Fibrosis-4 versus FibroScan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosis.
Tamaki N; Imajo K; Sharpton S; Jung J; Kawamura N; Yoneda M; Valasek MA; Behling C; Sirlin CB; Nakajima A; Loomba R
Hepatology; 2022 Mar; 75(3):661-672. PubMed ID: 34496054
[TBL] [Abstract][Full Text] [Related]
25. Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study.
Loomba R; Cui J; Wolfson T; Haufe W; Hooker J; Szeverenyi N; Ang B; Bhatt A; Wang K; Aryafar H; Behling C; Valasek MA; Lin GY; Gamst A; Brenner DA; Yin M; Glaser KJ; Ehman RL; Sirlin CB
Am J Gastroenterol; 2016 Jul; 111(7):986-94. PubMed ID: 27002798
[TBL] [Abstract][Full Text] [Related]
26. Transient Elastography and Ultrasonography: Optimal Evaluation of Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease.
Zhang GL; Zhao QY; Lin CS; Hu ZX; Zhang T; Gao ZL
Biomed Res Int; 2019; 2019():3951574. PubMed ID: 30809540
[TBL] [Abstract][Full Text] [Related]
27. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.
Xiao G; Zhu S; Xiao X; Yan L; Yang J; Wu G
Hepatology; 2017 Nov; 66(5):1486-1501. PubMed ID: 28586172
[TBL] [Abstract][Full Text] [Related]
28. The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis.
Alsaqal S; Hockings P; Ahlström H; Gummesson A; Hedström A; Hulthe J; Johansson L; Niessen HG; Schoelch C; Schultheis C; Vessby J; Wanders A; Rorsman F; Ebeling Barbier C
J Magn Reson Imaging; 2022 Aug; 56(2):368-379. PubMed ID: 34953171
[TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance elastography in the assessment of hepatic fibrosis: a study comparing transient elastography and histological data in the same patients.
Toguchi M; Tsurusaki M; Yada N; Sofue K; Hyodo T; Onoda M; Numoto I; Matsuki M; Imaoka I; Kudo M; Murakami T
Abdom Radiol (NY); 2017 Jun; 42(6):1659-1666. PubMed ID: 28144720
[TBL] [Abstract][Full Text] [Related]
30. A comparison of FibroMeter™ NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease.
Aykut UE; Akyuz U; Yesil A; Eren F; Gerin F; Ergelen R; Celikel CA; Yilmaz Y
Scand J Gastroenterol; 2014 Nov; 49(11):1343-8. PubMed ID: 25259621
[TBL] [Abstract][Full Text] [Related]
31. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
[TBL] [Abstract][Full Text] [Related]
32. Comparison of point shear wave elastography and transient elastography in the evaluation of patients with NAFLD.
Argalia G; Ventura C; Tosi N; Campioni D; Tagliati C; Tufillaro M; Cucco M; Svegliati Baroni G; Giovagnoni A
Radiol Med; 2022 May; 127(5):571-576. PubMed ID: 35290569
[TBL] [Abstract][Full Text] [Related]
33. Comparison of magnetic resonance elastography and transient elastography in the diagnosis of hepatic fibrosis: a systematic review and meta-analysis.
Bi J; Liu L; Qin T
Ann Palliat Med; 2021 Aug; 10(8):8692-8700. PubMed ID: 34488358
[TBL] [Abstract][Full Text] [Related]
34. Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C.
Bohte AE; de Niet A; Jansen L; Bipat S; Nederveen AJ; Verheij J; Terpstra V; Sinkus R; van Nieuwkerk KM; de Knegt RJ; Baak BC; Jansen PL; Reesink HW; Stoker J
Eur Radiol; 2014 Mar; 24(3):638-48. PubMed ID: 24158528
[TBL] [Abstract][Full Text] [Related]
35. Transient Elastography Is the Best-Performing Non-Invasive Test of Liver Fibrosis in Obese Asian Patients with Non-Alcoholic Fatty Liver Disease: A Pilot, Cross-Sectional Study.
Kalaiyarasi K; Sanchalika A; Hsien Min L; Wei Ming Y; Vishalkumar S; Kuo Chao Y; Jee Keem L; Sameer J; Terence HCW; Yen Ping T
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256429
[No Abstract] [Full Text] [Related]
36. Serum cytokeratin-18 and its relation to liver fibrosis and steatosis diagnosed by FibroScan and controlled attenuation parameter in nonalcoholic fatty liver disease and hepatitis C virus patients.
Darweesh SK; AbdElAziz RA; Abd-ElFatah DS; AbdElazim NA; Fathi SA; Attia D; AbdAllah M
Eur J Gastroenterol Hepatol; 2019 May; 31(5):633-641. PubMed ID: 30839434
[TBL] [Abstract][Full Text] [Related]
37. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants.
Ajmera V; Kim BK; Yang K; Majzoub AM; Nayfeh T; Tamaki N; Izumi N; Nakajima A; Idilman R; Gumussoy M; Oz DK; Erden A; Quach NE; Tu X; Zhang X; Noureddin M; Allen AM; Loomba R
Gastroenterology; 2022 Oct; 163(4):1079-1089.e5. PubMed ID: 35788349
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic accuracy of magnetic resonance elastography in liver transplant recipients: A pooled analysis.
Singh S; Venkatesh SK; Keaveny A; Adam S; Miller FH; Asbach P; Godfrey EM; Silva AC; Wang Z; Murad MH; Asrani SK; Lomas DJ; Ehman RL
Ann Hepatol; 2016; 15(3):363-76. PubMed ID: 27049490
[TBL] [Abstract][Full Text] [Related]
39. Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD).
Han MA; Saouaf R; Ayoub W; Todo T; Mena E; Noureddin M
Expert Rev Clin Pharmacol; 2017 Apr; 10(4):379-390. PubMed ID: 28277807
[TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.
Loomba R; Wolfson T; Ang B; Hooker J; Behling C; Peterson M; Valasek M; Lin G; Brenner D; Gamst A; Ehman R; Sirlin C
Hepatology; 2014 Dec; 60(6):1920-8. PubMed ID: 25103310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
